0000950142-13-001764.txt : 20130807
0000950142-13-001764.hdr.sgml : 20130807
20130807104946
ACCESSION NUMBER: 0000950142-13-001764
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130806
FILED AS OF DATE: 20130807
DATE AS OF CHANGE: 20130807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KV PHARMACEUTICAL CO /DE/
CENTRAL INDEX KEY: 0000057055
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 430618919
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 2280 SCHUETZ ROAD
CITY: ST. LOUIS
STATE: MO
ZIP: 63146
BUSINESS PHONE: 3146456600
MAIL ADDRESS:
STREET 1: 2280 SCHUETZ ROAD
CITY: ST. LOUIS
STATE: MO
ZIP: 63146
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROBBINS LAWRENCE M
CENTRAL INDEX KEY: 0001228603
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09601
FILM NUMBER: 131016268
MAIL ADDRESS:
STREET 1: 767 FIFTH AVENUE
STREET 2: 44TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10153
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GLENVIEW CAPITAL MANAGEMENT, LLC
CENTRAL INDEX KEY: 0001138995
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09601
FILM NUMBER: 131016269
BUSINESS ADDRESS:
STREET 1: 767 FIFTH AVENUE
STREET 2: 44TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10153
BUSINESS PHONE: 2128124700
MAIL ADDRESS:
STREET 1: 767 FIFTH AVENUE
STREET 2: 44TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10153
FORMER NAME:
FORMER CONFORMED NAME: GLENVIEW CAPITAL MANAGEMENT LLC
DATE OF NAME CHANGE: 20010420
4/A
1
es1301001_4a-gvcllc.xml
OWNERSHIP DOCUMENT
X0306
4/A
2013-08-06
2013-08-07
1
0000057055
KV PHARMACEUTICAL CO /DE/
KVPHQ
0001138995
GLENVIEW CAPITAL MANAGEMENT, LLC
767 FIFTH AVENUE
44TH FLOOR
NEW YORK
NY
10153
0
0
1
0
0001228603
ROBBINS LAWRENCE M
767 FIFTH AVENUE
44TH FLOOR
NEW YORK
NY
10153
0
0
1
0
Class A Common Stock, $0.01 par value
2013-08-06
4
S
0
1764709
0.4649
D
4897274
I
See footnotes
These shares of the Issuer's Class A Common Stock, $0.01 par value per share (the "Shares") were purchased for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd. and Glenview Capital Opportunity Fund, L.P.
This price reflects the weighted average purchase price for open-market purchases of Shares made by the Reporting Persons on August 6, 2013 within a $1.00 range. The actual prices for these transactions range from $0.35 to $0.61, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., and Glenview Capital Opportunity Fund, L.P. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC. Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose.
This amended Form 4 corrects the "Transaction Code" column of the previously filed Form 4. Exhibit List: The Power of Attorney filed as Exhibit B to the Schedule 13D filed by the Reporting Persons on August 5, 2013 is incorporated herein by reference.
/s/ Mark J. Horowitz, Chief Operating Officer and General Counsel of Glenview Capital Management LLC
2013-08-07
/s/ Mark J. Horowitz, Attorney-in- Fact for Lawrence M. Robbins
2013-08-07